Literature DB >> 7858936

The management of cancer anemia.

D H Henry1.   

Abstract

Anemia is common in patients with cancer and is often exacerbated by myelosuppressive chemotherapy. If severe enough, the anemia may require red blood cell transfusion for symptomatic palliation. However, blood transfusion will never be completely safe. Inconvenience and acute transfusion reactions are a problem and there is still a small risk of hepatitis. In selected patients with cancer-related anemia, recombinant human erythropoietin is another option to consider for the symptomatic patient.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7858936     DOI： 10.1007/bf00344057

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


  6 in total

Review 1.  Progress in understanding the pathogenesis of the anemia of chronic disease.

Authors:  R T Means; S B Krantz
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

2.  Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis.

Authors:  T Pincus; N J Olsen; I J Russell; F Wolfe; E R Harris; T J Schnitzer; J A Boccagno; S B Krantz
Journal:  Am J Med       Date:  1990-08       Impact factor: 4.965

3.  Decreased erythropoietin response in patients with the anemia of cancer.

Authors:  C B Miller; R J Jones; S Piantadosi; M D Abeloff; J L Spivak
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

4.  Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients.

Authors:  L C Platanias; C B Miller; R Mick; R D Hart; H Ozer; J M McEvilly; R J Jones; M J Ratain
Journal:  J Clin Oncol       Date:  1991-11       Impact factor: 44.544

5.  Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia.

Authors:  C B Miller; L C Platanias; S R Mills; M L Zahurak; M J Ratain; D S Ettinger; R J Jones
Journal:  J Natl Cancer Inst       Date:  1992-01-15       Impact factor: 13.506

6.  Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.

Authors:  D H Henry; G N Beall; C A Benson; J Carey; L A Cone; L J Eron; M Fiala; M A Fischl; S J Gabin; M S Gottlieb
Journal:  Ann Intern Med       Date:  1992-11-01       Impact factor: 25.391
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.